Gluten Intolerance Treatment Market - Top Companies and Manufacturers

Companies Dominating the Gluten Intolerance Treatment Landscape

Takeda Pharmaceutical Company Limited
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

ActoBio Therapeutics, Inc.
Precigen, Inc.
Calypso Biotech BV
ImmunogenX, Inc.
Alvine Pharmaceuticals
Dr. Falk Pharma GmbH
ImmusanT, Inc.
Zedira GmbH
FunZyme BioTechnologies S.A.
Amyra Biotech AG

Browse Key Market Insights with Data Illustration:

Gluten Intolerance Treatment Market Size Forecasts 2036

In the News

ActoBio Therapeutics, Inc., a wholly-owned subsidiary of Intrexon Corporation announced that the U.S. Food and Drug Administration (FDA) has given its permission to an Investigational New Drug (IND) application for AG017. It is an innovative orally-delivered therapeutic candidate for the treatment of celiac disease.
Takeda Pharmaceutical Company Limited, Zedira GmbH and Dr. Falk Pharma GmbH announced a collaboration and licensing agreement to develop ZED1227/TAK-227. TAK-227 is a Phase 2b investigational therapy for the treatment of celiac disease designed to prevent the immune response to gluten in celiac disease, a serious autoimmune disease where the ingestion of gluten leads to inflammation and damage to the small intestine.

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of gluten intolerance treatment is estimated at USD 832.97 Million.

The gluten intolerance treatment market size was valued at USD 740.35 Million in 2023 and is likely to cross USD 4.02 Billion by the end of 2036, registering more than 13.9% CAGR during the forecast period i.e., between 2024-2036. The growing prevalence of autoimmune, allergic, and non-autoimmune-allergic GRDs and the rising damage of gut flora are the major factors driving the market growth.

Asia Pacific region is projected to account for 25% revenue share by 2036, due to growing concern about gluten intolerance in the region.

Takeda Pharmaceutical Company Limited, ActoBio Therapeutics, Inc., Precigen, Inc., Calypso Biotech BV, ImmunogenX, Inc., Alvine Pharmaceuticals, Dr. Falk Pharma GmbH, ImmusanT, Inc., Zedira GmbH, FunZyme BioTechnologies S.A., Amyra Biotech AG

Gluten Intolerance Treatment Market - Top Companies and Manufacturers

Companies Dominating the Gluten Intolerance Treatment Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What is the size of the gluten intolerance treatment market?

Why is the gluten intolerance treatment sector gaining traction in near future?

Which region accounted for the largest gluten intolerance treatment industry share?

Who are the major gluten intolerance treatment players?